Dhananjay Chitale

Michigan Department of Health and Human Services — United States

Biochemistry, Genetics and Molecular Biology · Life Sciences

39h-index9.7kcitations267works0.22yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer Genomics and Diagnostics(55), Prostate Cancer Treatment and Research(38), Breast Cancer Treatment Studies(27), Prostate Cancer Diagnosis and Treatment(24), Lung Cancer Treatments and Mutations(23)

Publications265 total

Demand Forecasting with Machine Learning: A Data-Driven Strategy for Market Prediction
2025
Supplementary Figure from Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer
2025Open Access
Supplementary Table from Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer
2025Open Access
Supplementary Table from Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer
2025Open Access
Data from Race Differences in Telomere Length in Benign Prostate Biopsies and Subsequent Risk of Prostate Cancer
2025Open Access
Correction: Associations amongst genes, molecules, cells, and organs in breast cancer metastasis
Clinical & Experimental Metastasis·2025
Table S3 from p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer
2025Open Access
Figure S1 from p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer
2025Open Access
Data from p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer
2025Open Access
Table S2 from p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer
2025Open Access
Table S1 from p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer
2025Open Access
Abstract 3893: Enhanced detection of molecular subtypes in prostate cancer using saturation biopsy: Insights into tumor heterogeneity and racial disparities
Cancer Research·2025
Abstract 5624: The antiviral, Daclatasvir, disrupts ASCL1-EZH2 signaling and impairs survival of neuroendocrine prostate cancer cells
Cancer Research·2025
Abstract 3065: Tribbles 2 drives lineage maintenance and survival in neuroendocrine prostate cancer by regulating N-Myc stability
Cancer Research·2025
p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer
Cancer Epidemiology Biomarkers & Prevention·2025· 1 citedOpen Access
Comparison of fluorescence in situ hybridization and cytology for the accurate detection of malignant biliary strictures, with emphasis on unusual results
Journal of the American Society of Cytopathology·2025· 1 cited
Clinicopathologic characteristics of ductal carcinoma in situ and risk of subsequent invasive breast cancer: a multicenter, population-based cohort study
Breast Cancer Research and Treatment·2025· 1 citedOpen Access
Higher expression of mir‐31‐5p is associated with reduced risk of head and neck keloid recurrence following surgical resection
Laryngoscope Investigative Otolaryngology·2024Open Access
EP.13E.04 Racial Disparities in Genomic Subtypes of Small Cell Lung Cancer Patients
Journal of Thoracic Oncology·2024
Unveiling Prostate Cancer's Molecular Tapestry: Ethnic Disparities and Prognostic Insights from Whole-Mount Prostatectomy Tissue Analysis
2024Open Access
page 1 of 14Next →

Frequent Co-authors

Marc Ladanyi(15), William Pao(8), Valerie W. Rusch(7), David Nathanson(6), Lisa A. Newman(6), Benjamin A. Rybicki(6), Gregory J. Riely(5), Nilesh Gupta(5), Oleksandr N. Kryvenko(5), Stephen Broderick(4), Vincent A. Miller(4), Mark G. Kris(4), David B. Solit(4), Maureen F. Zakowski(4), Yalei Chen(4), Jessica Bensenhaver(4), Erica Proctor(4), Deliang Tang(4), Andrew Rundle(4), Sheri Trudeau(4)